Articles
February 06, 2012
NDCA Addresses Pre-Trial Procedure for Streamlining Patent Marking Defense
Fish & Richardson
January 03, 2012
NDCA clarifies that Marking turns on what claims are asserted, not what survives to trial
Fish & Richardson
December 02, 2011
Orange Book Listing Opportunities for Drug-Device Combinations
BNA Pharmaceutical Law & Industry Report
December 01, 2011
WD TN Grants New Trial on Damages after Remand Because the Reasonable Royalty Rate in the Original Verdict Was Based on the Now-Defunct 25%
Fish & Richardson
November 08, 2011
Inspiration or infringement?: Examining the Janine Gordon v. Ryan McGinley Photography Case
Intellectual Property Magazine
October 21, 2011
Is It Time for FDA to Revise Its Orange Book Rules to Deal with Skinny Labeled Generic Drugs?
FDLI's Food and Drug Policy Forum
August 12, 2011
EDTX Issues Pretrial Rulings on Reasonable Royalty and Lost Profits Damages
Fish & Richardson
August 10, 2011
New FDA Draft Guidance Sheds Light On Regulation of 'Mobile Medical Apps' and Other Software
BNA Medical Devices Law & Industry Report
August 08, 2011
NDTX Strikes One License and Allows Another; Finds Fault in Expert's Use of Entire Market Value Rule
Fish & Richardson
IP Law Essentials
-
What is the first step in the patent litigation process? What's a Markman hearing? Can you be sued at the International Trade Commission? Our IP Law Essentials series answers these questions and many more, providing a thorough introduction to IP law from some of the world's premier IP practitioners.